Mammary cancer resistance and precocious mammary differentiation in the WKY rat: Identification of 2 quantitative trait loci

International Journal of Cancer

Volumn 121, Issue 8, 2007, Pages 1738-1743

  Leila, Virginie ^a   Stieber, Daniel ^a   Rivière, Michèle ^a   Szpirer, Josiane ^a   Szpirer, Claude ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Cancer; Congenics; Differentiation; Mammary; Rat

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RESISTANCE; CHROMOSOME 18; CHROMOSOME 5; CONGENIC STRAIN; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT; RAT; TISSUE DIFFERENTIATION; WISTAR KYOTO RAT;

ANIMALS; CASEINS; CELL DIFFERENTIATION; CHROMOSOME MAPPING; CHROMOSOMES, MAMMALIAN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; PRECANCEROUS CONDITIONS; QUANTITATIVE TRAIT LOCI; RATS; RATS, INBRED WKY; RATS, MUTANT STRAINS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34548670040     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22924     Document Type: Article

References (40)

1. Martin AM, Weber BL. Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst 2000;92:1126-35.
2. Nathanson KL, Weber BL. "Other" breast cancer susceptibility genes: searching for more holy grail. Hum Mol Genet 2001;10:715-20.
3. Crawford NP, Hunter KW. New perspectives on hereditary influences in metastatic progression. Trends Genet 2006;22:555-61.
4. Kim M, Gans JD, Nogueira C, Wang A, Paik JH, Feng B, Brennan C, Hahn WC, Cordon-Cardo C, Wagner SN, Flotte TJ, Duncan LM, et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 2006;125:1269-81.
5. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, Mu D, Lucito R, et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006;125:1253-67.
6. Russo IH, Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 1996;104:938-67.
7. Russo J. Experimentally induced mammary tumors in rats. Breast Cancer Res Treat 1996;39:7-20.
8. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ. Biology of disease. Comparative study of human and rat mammary tumorigenesis. Lab Invest 1990;62:244-78.
9. Gould MN. Rodent models for the study of etiology, prevention and treatment of breast cancer. Semin Cancer Biol 1995;6:147-52.
10. Isaacs JT. Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res 1986;46:3958-63.
11. Isaacs JT. Inheritance of a genetic factor from the Copenhagen rat and the suppression of chemically induced mammary adenocarcinogenesis. Cancer Res 1988;48:2204-13.
12. Haag JD, Newton MA, Gould MN. Mammary carcinoma suppressor and susceptibility genes in the Wistar-Kyoto rat. Carcinogenesis 1992;13:1933-35.
13. Gould MN. Modulation of mammary carcinogenesis by enhancer and suppressor genes. In: Colburn NH, ed. Genes and signal transduction in multistage carcinogenesis. New York: Marcel Dekker, 1989.
14. Shepel LA, Lan H, Haag JD, Brasic GM, Gheen ME, Simon JS, Hoff P, Newton MA, Gould MN. Genetic identification of multiple loci that control breast cancer susceptibility in the rat. Genetics 1998;149:289-99.
15. Lan H, Kendziorski CM, Haag JD, Shepel LA, Newton MA, Gould MN. Genetic loci controlling breast cancer susceptibility in the Wistar-Kyoto rat. Genetics 2001;157:331-9.
16. Quan X, Laes JF, Stieber D, Riviere M, Russo J, Wedekind D, Coppieters W, Farnir F, Georges M, Szpirer J, Szpirer C. Genetic identification of distinct loci controlling mammary tumor multiplicity, latency, and aggressiveness in the rat. Mamm Genome 2006;17:310-21.
17. Gould KA, Tochacek M, Schaffer BS, Reindl TM, Murrin CR, Lachel CM, VanderWoude EA, Pennington KL, Flood LA, Bynote KK, Meza JL, Newton MA, et al. Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat: mapping of Emca1 and Emca2 to chromosomes 5 and 18. Genetics 2004;168:2113-25.
18. Schaffer BS, Lachel CM, Pennington KL, Murrin CR, Strecker TE, Tochacek M, Gould KA, Meza JL, McComb RD, Shull JD. Genetic bases of estrogen-induced tumorigenesis in the rat: mapping of loci controlling susceptibility to mammary cancer in a Brown Norway x ACI intercross. Cancer Res 2006;66:7793-800.
19. Shepel LA, Gould MN. The genetic components of susceptibility to breast cancer in the rat. Prog Exp Tumor Res 1999;35:158-69.
20. Moore CJ, Triconi WA, Gould MN. Comparison of 7,12-dimethylben[a] anthracen metabolism and DNA binding in mammary epithelial cells from three rat strains with differing susceptibilities to mammary carcinogenesis. Carcinogenesis 1988;9:2099-102.
21. Korkola JE, Archer MC. Resistance to mammary tumorigenesis in Copenhagen rats is associated with the loss of preneoplastic lesions. Carcinogenesis 1999;20:221-7.
22. Wood GA, Korkola JE, Archer MC. Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes. Carcinogenesis 2002;23:1-9.
23. Korkola JE, Wood GA, Archer MC. Resistance to chemically-induced mammary tumors in Copenhagen X nude-derived F2 athymic rats: evidence that T-cell immunity is not involved in Copenhagen resistance. Carcinogenesis 1997;18:53-7.
24. Gering KM, Marx JA, Lennartz K, Fischer C, Rajewsky MF, Kindler-Rohrborn A. The interaction mode of premalignant Schwann and immune effector cells during chemically induced carcinogenesis in the rat peripheral nervous system is strongly influenced by genetic background. Cancer Res 2006;66:4708-14.
25. Wood GA, Korkola JE, Archer MC. Resistance of Copenhagen rats to hepatocarcinogenesis does not involve T-cell immunity. Carcinogenesis 2001;22:357-9.
26. Kindler-Rohrborn A, Kind AB, Koelsch BU, Fischer C, Rajewsky MF. Suppression of ethylnitrosourea-induced schwannoma development involves elimination of neu/erbB-2 mutant premalignant cells in the resistant BDIV rat strain. Cancer Res 2000;60:4756-60.
27. De Miglio MR, Simile MM, Muroni MR, Calvisi DF, Virdis P, Asara G, Frau M, Bosinco GM, Seddaiu MA, Daino L, Feo F, Pascale RM. Phenotypic reversion of rat neoplastic liver nodules is under genetic control. Int J Cancer 2003;105:70-75.
28. Stieber D, Piessevaux G, Riviere M, Laes JF, Quan X, Szpirer J, Szpirer C. Isolation of two regions on rat chromosomes 5 and 18 affecting mammary cancer susceptibility. Int J Cancer 2007;120: 1678-83.
29. Russo IH, Russo J. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 1978;61:1439-49.
30. Benton ME, Chen KS, Haag JD, Sattler CA, Gould MN. Precocious differentiation of the virgin Wistar-Kyoto rat mammary gland. Endocrinology 1999;140:2659-71.
31. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 1982;2:5-73.
32. Russo J, Mailo D, Hu YF, Balogh G, Sheriff F, Russo IH. Breast differentiation and its implication in cancer prevention. Clin Cancer Res 2005;11:931s-936s.
33. Russo J, Russo IH. Cellular basis of breast cancer susceptibility. Oncol Res 1999;11:169-78.
34. Harris H. Putting on the brakes. Nature 2004;427:201.
35. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res 2006;66:1883-90.
36. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-8.
37. Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, Tan LK, Rosen JM, et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA 2003;100:15853-8.
38. Liu BY, McDermott SP, Khwaja SS, Alexander CM. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci USA 2004;101:4158-63.
39. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradim D, Pilotti S, Pierotti MA, Daidone MG. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005;65:5506-11.
40. Russo J, Balogh GA, Chen J, Fernandez SV, Fernbaugh R, Heulings R, Mailo DA, Moral R, Russo PA, Sheriff F, Vanegas JE, Wang R, et al. The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention. Front Biosci 2006;11:151-72.